| Gene: | F10 |
| GeneID: | ENSG00000126218 |
| Chrom: | 13 |
| Start position: | 113122799 |
| End position: | 113149529 |
| Pathway: | Complement and coagulation cascades |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0613128 |
| Number of nsSNPs: | 2 |
| nsSNPs in gene: | rs3211783
rs5961 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.80 (Driver) | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 4 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Enzyme |
| JensenLab PubMed score: | 1386.92 (Percentile rank: 96.82%) |
| PubTator score: | 3139.95 (Percentile rank: 99.01%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
